Zenith Drugs Ltd.

61.90 -0.75 ▼-1.2%

22 April 2024, 03:40:08 PM
Volume: 59,200

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.zenithdrugs.com
Market Cap 107.44 Cr.
Enterprise Value(EV) 129.88 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 3.01 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 20.85 Trailing Twelve Months Ending 2023-03
Industry PE 41.25 Trailing Twelve Months Ending 2023-03
Book Value / Share 10.00 Trailing Twelve Months Ending 2023-03
Price to Book Value 6.27 Calculated using Price: 62.65
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.71 Cr. 17,148,800 Shares
FaceValue 10
About Zenith Drugs Ltd.
The company is mainly engaged in the business of manufacturing and Trading of Medicines.

Zenith Drugs Ltd. Delivery

Delivered Qty
Traded Qty

Zenith Drugs Ltd. Performance

1 Day
-1.20%
1 Week
-3.13%
1 Month
-5.64%
3 Month
6 Month
1 Year
2 Year
5 Year
10 Year

Zenith Drugs Ltd. Fundamental Ratios

2 years 2022-03 2023-03
Return on Equity (%) 25.88 35.13
Return on Capital Employed (%) 21.51 26.57
Return on Assets (%) 4.56 6.19

Zenith Drugs Ltd. Balance Sheet

Particulars 2 years 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 12 17
Non Curr. Liab. 10 9
Curr. Liab. 47 72
Minority Int. 0 0
Equity & Liab. 69 98
Non Curr. Assets 15 14
Curr. Assets 54 84
Misc. Exp. not W/O
Total Assets 69 98

Zenith Drugs Ltd. Profit and Loss

Particulars 2 years 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 92 115
Other Income 1 1
Total Income 93 116
Total Expenditure -85 -105
PBIDT 8 11
Interest -2 -3
Depreciation -1 -1
Taxation -1 -2
Exceptional Items
PAT 3 5
Minority Interest
Share Associate 0
Other Related Items
Consolidated Net Profit 3 5
Adjusted EPS 3 4

Zenith Drugs Ltd. Cash Flow

Particulars 2 years 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 5 -4
Cash Fr. Inv. -5 0
Cash Fr. Finan. 1 5
Net Change 1 1
Cash & Cash Eqvt 3 4

Zenith Drugs Ltd. Shareholding Pattern

No shareholding pattern found.

Zenith Drugs Ltd. Announcements

Mon, 22 Apr 2024
Shareholders meeting
Zenith Drugs Limited has informed the Exchange regarding Postal Ballot Notice Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( SEBI Listing Regulations ).
Sat, 20 Apr 2024
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
Zenith Drugs Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Qtr ended 31st March, 2024 FY 2023-24
Wed, 17 Apr 2024
Diversification/Disinvestment
Zenith Drugs Limited has informed the Exchange about Diversification/Disinvestment

Zenith Drugs Ltd. Technical Scans

Mon, 22 Apr 2024
High Delivery Percentage High Delivery Percentage
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Decrease in 1 Month High Decrease in 1 Month
CCI Oversold Zone CCI Oversold Zone
Dragonfly Doji Dragonfly Doji

Zenith Drugs Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 369,401.61 1,542.35 +1.3%
Cipla Ltd. 109,341.46 1,355.75 +0.8%
Dr. Reddy's Laboratories Ltd. 100,341.19 6,000.00 +1.0%
Divi's Laboratories Ltd. 99,176.41 3,742.35 +2.0%
Zydus Lifesciences Ltd. 96,543.12 954.00 +3.4%
Mankind Pharma Ltd. 93,651.57 2,345.05 +0.4%
Apollo Hospitals Enterprise Ltd. 89,650.45 6,236.45 +1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.48 1,542.35 +1.3%
Cipla Ltd. Consolidated 2023-12 29.49 1,355.75 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.19 6,000.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 71.71 3,742.35 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.46 954.00 +3.4%
Mankind Pharma Ltd. Consolidated 2023-12 54.22 2,345.05 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 113.58 6,236.45 +1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.92 1,542.35 +1.3%
Cipla Ltd. Consolidated 2023-12 4.22 1,355.75 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.73 6,000.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.61 3,742.35 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.12 954.00 +3.4%
Mankind Pharma Ltd. Consolidated 2023-12 10.54 2,345.05 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.27 6,236.45 +1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,542.35 +1.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,355.75 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,000.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,742.35 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 954.00 +3.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,345.05 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,236.45 +1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,542.35 +1.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,355.75 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,000.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,742.35 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 954.00 +3.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,345.05 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,236.45 +1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,542.35 +1.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,355.75 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,000.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,742.35 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 954.00 +3.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,345.05 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,236.45 +1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,542.35 +1.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,355.75 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,000.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,742.35 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 954.00 +3.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,345.05 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,236.45 +1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,542.35 +1.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,355.75 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,000.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,742.35 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 954.00 +3.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,345.05 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,236.45 +1.1%

Zenith Drugs Ltd. FAQ's

What is Zenith Drugs share price?

Can I buy Zenith Drugs shares now?

What is the Market Cap of Zenith Drugs?

What are the key metrics to analyse Zenith Drugs?

What is the 52 Week High and Low of Zenith Drugs?

What is the trend of Zenith Drugs share price?